# Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke

> **NCT03889249** · PHASE3 · COMPLETED · sponsor: **University of Calgary** · enrollment: 1600 (actual)

## Conditions studied

- Stroke, Acute
- Thromboses, Intracranial

## Interventions

- **DRUG:** Tenecteplase
- **DRUG:** Alteplase

## Key facts

- **NCT ID:** NCT03889249
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-10
- **Primary completion:** 2022-04-26
- **Final completion:** 2023-04-30
- **Target enrollment:** 1600 (ACTUAL)
- **Last updated:** 2023-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03889249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03889249, "Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03889249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*